FIXX - Homology Medicines spikes on strategic review
2023-07-28 09:05:11 ET
More on Homology Medicines
- Homology announces peer-reviewed preclinical data publication on its AAVHSC16 capsid
- FDA lifts clinical hold on Homology Medicines' phenylketonuria trial
- Homology stock falls 11% as Canaccord cuts price target citing potentially prolonged clinical hold
- Oxford Biomedica completes deal with Homology Medicines to set up 1st US subsidiary
- Seeking Alpha’s Quant Rating on Homology Medicines
For further details see:
Homology Medicines spikes on strategic review